<?xml version='1.0' encoding='UTF-8'?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.2d1 20130915//EN" "http://jats.nlm.nih.gov/archiving/1.2d1/JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink">
  <front>
    <journal-meta id="journal-meta-1">
      <journal-title-group>
        <journal-title>Journal of Medical Biomedical and Applied Sciences</journal-title>
      </journal-title-group>
      <publisher>
        <publisher-name>Innovative Journal</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta id="article-meta-1">
      <title-group>
        <article-title id="at-2d2f35bb9b9c">Benign and Malignant Tumors of Parotid Gland: A Retrospective Two Year Study</article-title>
      </title-group>
      <contrib-group>
        <contrib id="c-2a4343d20f51" corresp="true">
          <name id="n-b938e35a2563">
            <surname>Reshi</surname>
            <given-names>Ruby</given-names>
          </name>
          <email>rubymuazzam@gmail.com</email>
          <xref id="x-1673c819ebd4" rid="a-7117ef64b051" ref-type="aff">1</xref>
        </contrib>
        <contrib id="c-1d709c805bee">
          <name id="n-e4ba17688932">
            <surname>Amin</surname>
            <given-names>Jibran</given-names>
          </name>
          <email>jibraanamin@gmail.com </email>
          <xref id="x-8749ba18e5d2" rid="a-677b9f2f4f5a" ref-type="aff">2</xref>
        </contrib>
        <contrib id="c-dc237bdf7130" corresp="true">
          <name id="n-4e9033915743">
            <surname>Jeelani</surname>
            <given-names>Tazeen</given-names>
          </name>
          <email>tazeenjeelani@gmail.com</email>
          <xref id="x-8f6fa16a16ad" rid="a-d1fb22ed1cb9" ref-type="aff">3</xref>
        </contrib>
        <contrib id="c-75f07f5f3717">
          <name id="n-a89e71921da8">
            <surname>Rasheed</surname>
            <given-names>Rabiya</given-names>
          </name>
          <email>spinningstars@gmail.com</email>
          <xref id="x-dd71ed96e6e4" rid="a-3745661a8178" ref-type="aff">4</xref>
        </contrib>
        <aff id="a-7117ef64b051">
          <institution>Prof. and Head  Department of Pathology Government Medical college Srinagar J&amp;K India.</institution>
        </aff>
        <aff id="a-677b9f2f4f5a">
          <institution>Senior resident Department of Pathology Government Medical college Srinagar J&amp;K India.</institution>
        </aff>
        <aff id="a-d1fb22ed1cb9">
          <institution>Lecturer Department of Pathology Government Medical college Srinagar J&amp;K India. </institution>
        </aff>
        <aff id="a-3745661a8178">
          <institution>Resident Department of Pathology Govt. Medical college Srinagar J&amp;K India</institution>
        </aff>
      </contrib-group>
      <abstract id="abstract-6c95ae8fe988">
        <title id="abstract-title-cd7d5586f32e">Abstract:</title>
        <p id="t-ba7feb8a8c19"><bold id="s-76399b66a442">Introduction: </bold>Parotid tumors affect 1in100,000 people, representing 2-3%of tumors of the head and neck and 80% of salivary gland tumors. The literature estimates that approximately 80% of these tumors are benign, with pleomorphic adenoma being the most common followed by Warthin’s tumor. Among the malignant tumors mucoepidermoid carcinoma is the commonest, followed by adenoid cystic carcinoma.</p>
        <p id="p-48e1c392841f"><bold id="s-07197326228d">Material methods: </bold>It was a retrospective study done from January 2016 to December 2017 in the department of pathology Government Medical college Srinagar.</p>
        <p id="p-43db9dce522c"><bold id="s-c9220935c191">Results: </bold>our study included 42 cases of parotid gland tumors. Out of 42 cases 25 were female and 17 were male patients. Thus the male to female ratio observed was 1:1.4. Pleomorphic adenoma (twenty cases) was the most frequent benign tumor followed by warthin’s tumor (five cases) while as mucoepidermoid carcinoma was the most frequently identified malignant tumor. </p>
        <p id="p-e2973c3df12c"><bold id="strong-4">Conclusion :</bold> pleomorphic adenoma is the most prevalent benign histological type while as mucoepidermoid carcinoma is commonest malignant tumor. Malignant tumors are more common in 5<sup id="superscript-1">th</sup> decade while as benign lesions are commoner in 4<sup id="superscript-2">th</sup> decade of life.</p>
        <p id="p-09b9be359c65"/>
      </abstract>
      <kwd-group id="kwd-group-1">
        <title>Keywords</title>
        <kwd>Pleomorphic Adenoma</kwd>
        <kwd>Warthins Tumor</kwd>
        <kwd>Mucoepidermoid Carcinoma.</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec>
      <title id="t-d72ec1a2c926">Introduction:</title>
      <p id="t-48489046428f">Tumours of salivary glands are rare constituting less than one percent of all tumors and 3% to 10% of the neoplasms of head and neck region<xref id="x-18a7498a2aff" rid="526087:11949090" ref-type="bibr">1</xref>. Parotid tumors affect 1in100,000 people, representing 2-3%of tumors of the head and neck and 80% of salivary gland tumors <xref id="x-13eefce29e46" rid="526087:11949091" ref-type="bibr">2</xref>. The literature estimates that approximately 80% of these tumors are benign, with pleomorphic adenoma being the most common followed by Warthin’s tumor <xref id="x-340e70bef661" rid="526087:11949092" ref-type="bibr">3</xref>. The parotid gland has a superficial lobe, lateral to the facial nerve, that comprises 4/5 of the glandular parenchyma, and a smaller deep lobe. As 90% of the tumors are located in the superficial lobe and thus, do not affect the facial nerve hence superficial parotidectomy with facial nerve preservation is the most often indicated surgical procedure, <xref id="x-be57ec34b1bc" rid="526087:11949093" ref-type="bibr">4</xref>.</p>
      <p id="p-590d91e766ef"> The most common manifestation of pleomorphic adenoma is the presence of a solitary, solid, firm, lobulated, painless, mobile nodular lesion with well-defined margins<xref id="x-e66ad6ef136a" rid="526087:11949094" ref-type="bibr">5</xref>. Among the malignant tumors mucoepidermoid carcinoma is the commonest, followed by adenoid cystic carcinoma. The presence of pain, facial paralysis, rapidly growing tumor with ill-defined margins, and skin infiltration should raise the suspicion of malignancy<xref id="x-57a68bf3b43e" rid="526087:11949093" ref-type="bibr">4</xref>. </p>
      <p id="p-284871251394"> The first diagnostic imaging assessment for parotid tumors is usually ultrasonography <xref id="x-9bcca6fe8111" rid="526087:11949094" ref-type="bibr">5</xref>. Fine-needle aspiration cytology (FNAC), whether or not guided by ultrasound, can be used as a complementary diagnostic test, especially when a non-characteristic manifestation of pleomorphic adenoma is suspected. The purpose of FNA is to differentiate benign from malignant lesions, as it usually does not establish the definitive histological diagnosis. However, histopathology remains the gold standard as it avoids diagnostic pitfalls of FNAC<xref rid="526087:11949092" ref-type="bibr">3</xref>,<xref rid="526087:11949093" ref-type="bibr">4</xref>. </p>
      <p id="p-645ca98e3050"/>
    </sec>
    <sec>
      <title id="t-96b2065b7ff1">Materials and Methods:</title>
      <p id="t-1bc1574616e3">It was a single institute retrospective study done from January 2016 to December 2017 in the department of pathology Government Medical college Srinagar. Clinical data and gross features of tumours were recorded and tabulated. Haematoxylin and eosin (H&amp;E) stained sections and corresponding paraffin tissue blocks were retrieved from the archives of the department and reviewed. The tumors were categorized according to the WHO classification. </p>
      <p id="p-a5385532cb12">  </p>
      <fig id="f-ba928eee379d" position="here" orientation="potrait" width="onecolumn" fig-type="graphic">
        <graphic id="g-355e43c29c09" xlink:href="https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/b9586e55-3d05-4df5-88b9-1aafe736fa74/image/a28007b6-52bb-44a5-a75b-ce10f101a0ec-unew-picture.png"/>
        <label>Figure 1 </label>
        <caption id="c-167107d412cf">
          <title id="t-66a2b191b8df">pleomorphic adenoma consisting of mixedepithelial and mesenchymal cell component showing chondromatousdifferentiation.</title>
        </caption>
      </fig>
      <p id="p-1b2a9e3da2ba"/>
      <p id="p-2245f3662027">  </p>
      <fig id="f-31e009b79bbd" position="here" orientation="potrait" width="onecolumn" fig-type="graphic">
        <graphic id="g-82d7703ce518" xlink:href="https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/b9586e55-3d05-4df5-88b9-1aafe736fa74/image/73a46456-3918-4e8a-96e4-ef05e6bf2945-unew-picture-11.png"/>
        <label>Figure 2 </label>
        <caption id="c-bf424153568a">
          <title id="t-f1ae0cb3fbe6">photomicrograph showing warthin’s tumor lined bylayer of epithelial cells resting on dense lymphoid stroma with variable germinalcenters.  </title>
        </caption>
      </fig>
      <p id="p-82d6a026c7fd"/>
      <p id="p-8f2d9eab23f4">   </p>
      <fig id="f-129abb07fe1b" position="here" orientation="potrait" width="onecolumn" fig-type="graphic">
        <graphic id="g-1901583e4e7c" xlink:href="https://typeset-prod-media-server.s3.amazonaws.com/article_uploads/b9586e55-3d05-4df5-88b9-1aafe736fa74/image/0c0fdb80-b2a7-46c9-80f5-d471f0149b87-unew-picture.png"/>
        <label>Figure 3 </label>
        <caption id="c-4fdcd31806cf">
          <title id="t-9cba8d3d1d24">low grade mucoepidermoid carcinoma showingintermediate cells with bland nuclei forming glandular spaces intermixed withmucinous areas.  </title>
        </caption>
      </fig>
      <p id="p-d2fecc4a34e5"/>
    </sec>
    <sec>
      <title id="t-c95617694206">Results:</title>
      <p id="t-d3df830cab40">During the period of two years a total of 69 salivary gland surgeries were performed, which included 42 (60.8%) parotidectomies. Thus, our study included only these 42 cases of parotid gland tumors. The demographic analysis is given in <xref id="x-bbd376f5eeec" rid="tw-701f697f2e5b" ref-type="table">Table 1</xref>. Out of 42 cases 25 were female and 17 were male patients. Thus the male to female ratio observed was 1:1.4. At presentation, the main finding was a tumor mass measuring &gt;2cm in size in 73.8% of all cases reported in our study. Superficial lobe of parotid gland was the commonest site involved in Pleomorphic adenoma (twenty cases) <xref id="x-a45a2194636c" rid="f-ba928eee379d" ref-type="fig">Figure 1</xref> was the most frequent benign tumor followed by warthin’s tumor <xref id="x-6a8352f5762b" rid="f-31e009b79bbd" ref-type="fig">Figure 2</xref> (five cases) while as mucoepidermoid carcinoma <xref id="x-560a794cceb1" rid="f-129abb07fe1b" ref-type="fig">Figure 3</xref>  was the most frequently identified malignant tumor (three cases)<xref id="x-c06596bb1bbb" rid="tw-8c6300acb3e6" ref-type="table">Table 2</xref>. </p>
      <p id="p-ac96f8c57785"> The most relevant clinical characteristics of the benign and malignant tumors are shown in <xref id="x-b55bae507fd8" rid="tw-aa32167f3676" ref-type="table">Table 3</xref>. The ratio between men and women for malignant tumors was1:2, while for benign tumors it was 1:1.4. The mean age for the presentation of benign tumors was 46 years and for malignant tumors was 58 years. </p>
      <table-wrap id="tw-701f697f2e5b" orientation="potrait" position="here" width="twocolumn">
        <label>Table 1</label>
        <caption id="c-1ced130f20e7">
          <title id="t-907607855bdd">Demographic analysis of data </title>
        </caption>
        <table id="table-1" rules="rows">
          <colgroup/>
          <tbody id="table-section-1">
            <tr id="table-row-2">
              <td id="table-cell-2" align="left">Parameters</td>
              <td id="table-cell-3" align="left">Patients (%)</td>
            </tr>
            <tr id="table-row-3">
              <td id="table-cell-4" align="left">Females Males </td>
              <td id="table-cell-5" align="left">25 (59.5%)17 (40.5%)</td>
            </tr>
            <tr id="table-row-4">
              <td id="table-cell-6" align="left">Median age (min-max)</td>
              <td id="table-cell-7" align="left">40 (10-98)</td>
            </tr>
            <tr id="table-row-5">
              <td id="table-cell-8" align="left">Side Superficial and deep</td>
              <td id="table-cell-9" align="left">17 (40.4%)1 (2.3%)</td>
            </tr>
            <tr id="table-row-6">
              <td id="table-cell-10" align="left">Size ≤2 cm</td>
              <td id="table-cell-11" align="left">31 (73.8%)11 (26.2%)</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p id="paragraph-32"> </p>
      <table-wrap id="tw-8c6300acb3e6" orientation="potrait" position="here" width="twocolumn">
        <label>Table 2</label>
        <caption id="c-fcdaa12c4bce">
          <title id="t-03f1af7ab3b7">Histological  typing of parotid tumors  </title>
        </caption>
        <table id="table-2" rules="rows">
          <colgroup/>
          <tbody id="table-section-2">
            <tr id="table-row-8">
              <td id="table-cell-13" align="left">Histology</td>
              <td id="table-cell-14" align="left">Patients (%)</td>
            </tr>
            <tr id="table-row-9">
              <td id="table-cell-15" align="left">Benign tumors </td>
              <td id="table-cell-16" align="left">36 (85.7%)1 (2.7%)</td>
            </tr>
            <tr id="table-row-10">
              <td id="table-cell-17" align="left">Malignant tumors </td>
              <td id="table-cell-18" align="left">6 (14.3%)1 (16.6%)</td>
            </tr>
            <tr id="table-row-11">
              <td id="table-cell-19" align="left">Total</td>
              <td id="table-cell-20" align="left">42</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <table-wrap id="tw-aa32167f3676" orientation="potrait" position="here" width="twocolumn">
        <label>Table 3</label>
        <caption id="c-c540a17044d3">
          <title id="t-94e383403b01">Clinicalcharacteristics of benign and malignant tumors.</title>
        </caption>
        <table id="table-3" rules="rows">
          <colgroup/>
          <tbody id="table-section-3">
            <tr id="table-row-13">
              <td id="table-cell-22" align="left">Characteristic </td>
              <td id="table-cell-23" align="left">Benign</td>
              <td id="table-cell-24" align="left">Malignant</td>
            </tr>
            <tr id="table-row-14">
              <td id="table-cell-25" align="left"> Number of patients Men/women</td>
              <td id="table-cell-26" align="left">3615/21 </td>
              <td id="table-cell-27" align="left">62/4</td>
            </tr>
            <tr id="table-row-15">
              <td id="table-cell-28" align="left"> Mean age in years </td>
              <td id="table-cell-29" align="left">46</td>
              <td id="table-cell-30" align="left">58</td>
            </tr>
            <tr id="table-row-16">
              <td id="table-cell-31" align="left"> Superficial/deep/both</td>
              <td id="table-cell-32" align="left">35/1/0</td>
              <td id="table-cell-33" align="left">4/1/1</td>
            </tr>
          </tbody>
        </table>
      </table-wrap>
      <p id="p-7abfc3690bc5"/>
    </sec>
    <sec>
      <title id="t-0571a74aa58a"> Discussion:</title>
      <p id="t-0450db42c3f3">It<bold id="s-94c54b1f653f"> </bold> is essential for the surgeon to have the knowledge in parotid tumors as it is important at the time of diagnosis and treatment. The scientific literature includes some institutional experience in this matter, with most results indicating that benign tumors are the most frequent. Our study also confirms the prevalence of benign tumors in 85.7% of the population studied, close to the proportion reported in other studies, which demonstrate consensus regarding pleomorphic adenoma as the most frequent diagnosis of parotid tumors<xref id="x-daadb30c04b8" rid="526087:11949092" ref-type="bibr">3</xref>. As for malignancy, mucoepidermoid carcinoma represents 7% of the studied cases. In 2002, Sungur found an equivalent proportion of malignant tumors in their study. In 2008, studies showed a higher prevalence of mucoepidermoid carcinoma <xref id="x-029ba9422d39" rid="526087:11949093" ref-type="bibr">4</xref>. Mass palpation at parotid gland topography was the main manifestation at the physical examination in the study population, in 93.9% of cases, in agreement with the literature <xref id="x-be9e29097c34" rid="526087:11949095" ref-type="bibr">6</xref>. Most of the malignant tumours in the study were seen in the fifth decades while as benign tumours were more common in fourth decade of life <xref id="x-5ccd67497609" rid="526087:11949096" ref-type="bibr">7</xref>. In our study, females outnumbered males in both benign and malignant group. Many studies show that females are more frequently affected, there is some gender variation in different types of tumors <xref id="x-8beb7a36e9f7" rid="526087:11949097" ref-type="bibr">8</xref>.</p>
      <p id="p-e59703395c0f"/>
    </sec>
    <sec>
      <title id="t-d57bd06f1d57">Conclusion:</title>
      <p id="t-016c5477add7">The pleomorphic adenoma is the most prevalent benign histological type while as mucoepidermoid carcinoma is commonest malignant tumor. Malignant tumors are more common in 5<sup id="s-bc19f7e2e074">th</sup> decade while as benign lesions are commoner in 4<sup id="s-916f720e2637">th</sup> decade of life. Both benign and malignant tumors are more prevalent in females than in males.</p>
      <p id="p-c29a17df88c1"><bold id="s-40887a4b4acb">Conflict of interest</bold>: none <bold id="s-33372eea46ba"/></p>
      <p id="p-e5b99cd31082"/>
      <p id="p-c9bd137f9835"> </p>
      <p id="p-5f7db52cca1d"> </p>
      <p id="p-b3a60410a3af"> </p>
      <p id="paragraph-24e7add6e01c"> </p>
      <p id="p-5faf1f118a38"/>
    </sec>
  </body>
  <back>
    <ref-list id="526087">
      <title>References</title>
      <ref id="526087:11949090">
        <element-citation publication-type="misc">
          <person-group/>
          <person-group/>
          <article-title>Pons-Vicente O, Almendros-Marqués N, Berini-Aytés L, Gay Escoda C. Minor salivary gland tumors:A clonicopathological study of 18 cases. Med Oral Pathol Oral Cir Bucal</article-title>
          <volume>13</volume>
          <fpage>582</fpage>
          <lpage>8</lpage>
        </element-citation>
      </ref>
      <ref id="526087:11949091">
        <element-citation publication-type="journal">
          <person-group/>
          <person-group/>
          <article-title>Shashinder S, Tang IP, Velayutham P, Prepageran N, Gopala KG,Kuljit S, et al. A review of parotid tumors and their management:a ten-year-experience</article-title>
          <source>Med J Malasia</source>
          <volume>64</volume>
          <fpage>31</fpage>
          <lpage>3</lpage>
        </element-citation>
      </ref>
      <ref id="526087:11949092">
        <element-citation publication-type="journal">
          <person-group/>
          <person-group/>
          <article-title>Lin CC, Tsai MH, Huang CC, Hua CH, Tseng HC, Huang ST. Parotidtumors: a 10 year experience</article-title>
          <source>Am J Otolaryngol</source>
          <volume>29</volume>
          <fpage>94</fpage>
          <lpage>100</lpage>
        </element-citation>
      </ref>
      <ref id="526087:11949093">
        <element-citation publication-type="journal">
          <person-group/>
          <person-group/>
          <article-title>Sungur N, Akan IM, Ulusoy MG, Ozdemir R, Kilinc¸ H, Ortak T.Clinicopathological evaluation of parotid gland tumors: a retrospective study</article-title>
          <source>J Craniofacial Surg</source>
          <volume>13</volume>
          <fpage>2</fpage>
          <lpage>30</lpage>
        </element-citation>
      </ref>
      <ref id="526087:11949094">
        <element-citation publication-type="journal">
          <person-group/>
          <person-group/>
          <article-title>Maahs GS, Oppermann PO, Maahs LGP, Machado Filho G, Ronchi AD. Parotid gland tumors: a retrospective study of 154 patients</article-title>
          <source>Braz J Otorhinolaryngol</source>
          <volume>81</volume>
          <fpage>301</fpage>
          <lpage>6</lpage>
        </element-citation>
      </ref>
      <ref id="526087:11949095">
        <element-citation publication-type="journal">
          <person-group/>
          <person-group/>
          <article-title>Upton DC, McNamar JP, Connor NC, Harari PM, Hartig GK. Parotidectomy: tem-year review of 237 cases at a single institution</article-title>
          <source>Otolaryngol Head Neck</source>
          <volume>136</volume>
          <fpage>788</fpage>
          <lpage>92</lpage>
        </element-citation>
      </ref>
      <ref id="526087:11949096">
        <element-citation publication-type="book">
          <person-group person-group-type="editor">
            <name>
              <surname>Barnes</surname>
              <given-names>L.</given-names>
            </name>
            <name>
              <surname>Eveson</surname>
              <given-names>J.W.</given-names>
            </name>
            <name>
              <surname>Reichart</surname>
              <given-names>P.</given-names>
            </name>
            <name>
              <surname>DWorld</surname>
              <given-names>Sidransky</given-names>
            </name>
          </person-group>
          <article-title>Everson JW, Auclair P, Gnepp DR, Ei-Naggar AK. Tumors of the salivary glands</article-title>
          <publisher-name>IARC Press</publisher-name>
          <publisher-loc>Lyon</publisher-loc>
          <fpage>2005</fpage>
          <lpage>209</lpage>
        </element-citation>
      </ref>
      <ref id="526087:11949097">
        <element-citation publication-type="journal">
          <person-group/>
          <person-group/>
          <article-title>Kızıl Y, Aydil U, Ekinci O, Dilci A, Köybaşıoğlu A, Düzlü M, et al. Salivary Gland Tumors in Turkey: Demographic Features and Histopathological Distribution of 510 Patients</article-title>
          <source>Indian J Otolaryngol, Head Neck Surg</source>
          <volume>2013</volume>
          <fpage>65</fpage>
          <lpage>1</lpage>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
